Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Dapoxetine and Mirodenafil in Healthy Males
NCT02485041Phase 1Completed
- Sponsor
- SK Chemicals
- Start
- Nov 2014
- Primary completion
- Dec 2014
- Modality
- Covalent Small Molecules, Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of mirodenafil in erectile dysfunction (ED) (6 arms), sponsored by SK Chemicals. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Nov 2014; status: completed.
02
Drugs
mirodenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02485041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485041.